Aside from TGF-β expression, high-risk patients had greater levels of IL-6, IL-10, and FOXP3 expression, indicating an intense immunosuppressive microenvironment, which may facilitate immune escape and a poor prognosis for BC patients in the high-risk group (Figure 5B). This evidence concerns the gene TGFB1 and breast cancer.